F.D.A. Authorizes a New Covid Drug to Protect High-Risk People

The Food and Drug Administration has greenlit a new medicine to protect some of the people most at risk from Covid. The agency granted emergency use authorization for Pemgarda, a monoclonal antibody infusion, in immunocompromised people ages 12 and older. The drug is intended to protect against Covid for people who are not likely to… Continue reading F.D.A. Authorizes a New Covid Drug to Protect High-Risk People

We Are in a Big Covid Wave. But Just How Big?

The curves on some Covid graphs are looking quite steep, again. Reported levels of the virus in U.S. wastewater are higher than they have been since the first Omicron wave, according to data from the Centers for Disease Control and Prevention, though severe outcomes still remain rarer than in earlier pandemic winters. “We are seeing… Continue reading We Are in a Big Covid Wave. But Just How Big?

Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

As Covid rises again, killing about 1,500 Americans each week, medical researchers are trying to understand why so few people are taking Paxlovid, a medicine that is stunningly effective in preventing severe illness and death from the disease. A study of a million high-risk people with Covid found that only about 15 percent who were… Continue reading Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

Florida Health Official Calls for Halt to Covid Vaccines

Florida’s surgeon general on Wednesday called for a halt to the use of Covid vaccines, citing widely debunked concerns that contaminants in the vaccine can permanently integrate into human DNA. “These vaccines are not appropriate for use in human beings,” Dr. Joseph Ladapo, the state’s surgeon general and highest-ranking health official, said in a statement… Continue reading Florida Health Official Calls for Halt to Covid Vaccines

Covid Has Resurged, but Scientists See a Diminished Threat

The holidays have come and gone, and once again Americans are riding a tide of respiratory ailments, including Covid. But so far, this winter’s Covid uptick seems less deadly than last year’s, and much less so than in 2022, when the Omicron surge ground the nation to a halt. “We’re not seeing the signs that… Continue reading Covid Has Resurged, but Scientists See a Diminished Threat

Covid Variant JN.1 Now Accounts for Nearly Half of U.S. Cases

As the holiday season winds down and Covid-19 cases start to pick up, a variant called JN.1 has now become the most common strain of the virus spreading across the United States. JN.1, which emerged from the variant BA.2.86 and was first detected in the United States in September, accounted for 44 percent of Covid… Continue reading Covid Variant JN.1 Now Accounts for Nearly Half of U.S. Cases

New Covid Vaccines Hit Insurance Snags: What to Do if Yours Gets Denied

Vero Lopez was excited about getting the new Covid vaccine. She’s cautious about the virus, still carrying a mask around and avoiding indoor dining. So Ms. Lopez, 52, contacted her health care provider, Kaiser Permanente, as soon as she found out the shots were approved last week. She couldn’t get the vaccine through them yet,… Continue reading New Covid Vaccines Hit Insurance Snags: What to Do if Yours Gets Denied

U.S. Will Resume Offering Free At-Home Covid Tests

The Biden administration, looking ahead to a possible winter surge of Covid-19, announced on Wednesday that it was reviving its program of offering Americans free coronavirus tests through the mail and would spend more than $600 million to buy tests from a dozen domestic manufacturers. The website for the program, covidtests.gov, will begin accepting orders… Continue reading U.S. Will Resume Offering Free At-Home Covid Tests

F.D.A. Approves New Covid Shots

A nationwide rollout of the vaccines by Pfizer and Moderna should begin later this week, after the C.D.C. considers guidelines to prepare Americans for this season when infections usually tick upward. Source link